JP2003070466A - Artificial hair-bulb and method for producing the same, and method for assessing cosmetological agent by using the same - Google Patents

Artificial hair-bulb and method for producing the same, and method for assessing cosmetological agent by using the same

Info

Publication number
JP2003070466A
JP2003070466A JP2001269277A JP2001269277A JP2003070466A JP 2003070466 A JP2003070466 A JP 2003070466A JP 2001269277 A JP2001269277 A JP 2001269277A JP 2001269277 A JP2001269277 A JP 2001269277A JP 2003070466 A JP2003070466 A JP 2003070466A
Authority
JP
Japan
Prior art keywords
hair
cell
cells
artificial
test drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001269277A
Other languages
Japanese (ja)
Other versions
JP4822635B2 (en
Inventor
Takayuki Arai
孝之 荒井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP2001269277A priority Critical patent/JP4822635B2/en
Publication of JP2003070466A publication Critical patent/JP2003070466A/en
Application granted granted Critical
Publication of JP4822635B2 publication Critical patent/JP4822635B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a cell-culturing material capable of maximally reflecting the conditions of actual hair follicles or hair-bulbs, therefore providing a new means of assessing hair growers, and to provide the assessing means using the above material. SOLUTION: Under the consideration that if two-layer-structured cell clusters in such a condition that epithelial cells adhere around follicular mesenchymal cell clusters due to cellular screening can be formed, it is possible to provide a cell-culturing material enabling investigating hair-growing effect in such a state that human hair-bulb-like structure is reconstructed, the objective artificial hair-bulbs where epithelial cells adhere to the outside of follicular mesenchymal cell clusters, and the other objective method for assessing, by using the artificial hair-bulbs, cosmetological agents having hair growing effect or the like through acting on the hair, are provided, respectively.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、薬剤の新たな評価
手段を提供し得る素材に関する発明である。
TECHNICAL FIELD The present invention relates to a material capable of providing a new drug evaluation means.

【0002】[0002]

【従来の技術】育毛剤は、頭髪の成長を促進または刺激
するという積極的な効能を有する薬剤であり、高齢化社
会を迎えた今日では、年々、その需要は増大するものと
考えられ、それに呼応するかのように、新しい発毛ない
し脱毛防止の薬剤が開発されつつある。
2. Description of the Related Art A hair restorer is a drug having a positive effect of promoting or stimulating hair growth, and it is considered that the demand for it will increase year by year in the aging society. As if in response, new hair growth or hair loss prevention agents are being developed.

【0003】現在、脱毛の原因として、1)男性ホルモ
ン関与による毛包機能の低下、2)毛包、毛球部の新陳
代謝機能の低下、3)頭皮生理機能の低下、4)頭皮の
緊張による局所血流障害、5)遺伝等が挙げられてお
り、これらの脱毛原因に着目した各種の特徴ある育毛剤
の開発のための努力が日夜行われている。
Presently, the causes of hair loss are 1) deterioration of hair follicle function due to male hormone involvement, 2) deterioration of metabolic function of hair follicles and hair bulbs, 3) deterioration of scalp physiological function, and 4) scalp tension. Local blood flow disorders, 5) inheritance, etc. are mentioned, and efforts are being made day and night to develop various characteristic hair-growth agents focusing on these causes of hair loss.

【0004】育毛剤を開発する際には、当然のことなが
ら、候補物質に育毛効果が認められるか否かを評価する
ための手段が必要である。現在、代表的な育毛剤の評価
法としては、マウス、ウサギ、ハムスター、サル等の動
物の皮膚を用いる方法、ヒトを用いる方法が挙げられ
る。動物を用いた方法は、動物の毛の成長を、毛の重さ
や長さ、発毛面積および発毛開始時期等を検討する評価
法である。動物の毛の成長の検討を行うに際しては、動
物の種、加齢、季節、飼料等に留意をする必要がある。
When developing a hair restorer, it is of course necessary to have a means for evaluating whether a candidate substance has a hair restorer effect. Currently, typical methods for evaluating hair restorers include a method using the skin of animals such as mice, rabbits, hamsters and monkeys, and a method using humans. The method using an animal is an evaluation method for examining the growth of animal hair, such as the weight and length of hair, the area of hair growth, and the time of initiation of hair growth. When examining the growth of animal hair, it is necessary to pay attention to the species of animals, aging, season, feed and the like.

【0005】育毛効果の最終的な評価には、ヒトを用い
た試験が必要となるが、ヒトにおける育毛効果の評価
は、個人的、部位的なばらつき、被験者のコントロール
が困難であること、日間、季節的変動が不明なことな
ど、解決すべき問題点が多く残されている。
[0005] A final test on humans is required for the final evaluation of the hair-growth effect. However, the evaluation of the hair-growth effect on humans involves individual and site variations, difficulty in controlling the subject, and However, there are many problems to be solved, such as unknown seasonal fluctuations.

【0006】[0006]

【発明が解決しようとする課題】現在、真に画期的な育
毛剤の開発には、発毛や脱毛機構の基礎的な解明と、地
道な薬剤の効果追求が必要とされると考えられており、
このため、発毛のメカニズムに着目した評価法を提供す
る試みが行われつつある。例えば、上記の動物やヒトを
用いる方法以外に、毛包の器官培養や毛包由来細胞の培
養等を用いる方法が試みられており、これらの培養法
は、育毛剤の評価のみならず、毛の成長の機序を解明す
るためにも有用であると考えられている。
At present, it is considered that the development of truly innovative hair-growth agents requires basic elucidation of hair growth and hair loss mechanisms and steady pursuit of the effects of agents. And
Therefore, attempts are being made to provide an evaluation method focusing on the mechanism of hair growth. For example, in addition to the above-mentioned methods using animals and humans, methods using hair follicle organ culture, hair follicle-derived cell culture, and the like have been attempted. It is also considered to be useful for elucidating the mechanism of growth of the.

【0007】しかしながら、現状では、これらの培養方
法が、実際の毛包や毛球部の状態を正確に反映し切れて
いないという面が否めない等の、様々な問題点が認めら
れている。
However, under the present circumstances, various problems have been recognized, such as the fact that these culture methods do not completely reflect the actual state of the hair follicle or the hair bulb portion, and the like.

【0008】そこで、本発明が解決すべき課題は、可能
な限り、実際の毛包や毛球部の状態を反映し得る、育毛
剤の新たな評価手段を提供し得る細胞培養素材を提供
し、かかる培養素材を用いた育毛剤の評価手段を提供す
ることにある。
[0008] Therefore, the problem to be solved by the present invention is to provide a cell culture material capable of providing a new means for evaluating a hair-growing agent, which can reflect the actual condition of the hair follicle and the hair bulb as much as possible. The object of the present invention is to provide a means for evaluating a hair restorer using such a culture material.

【0009】[0009]

【課題を解決するための手段】本発明者は、発毛機序を
念頭に置きつつ、育毛剤の新たな評価手段や、新たな毛
髪関連薬剤のスクリーニング手段を提供し得る新たな細
胞培養素材について鋭意検討を重ねた。その結果、毛包
間葉系細胞の細胞集塊の周りに、細胞選別によって上皮
系細胞が細胞接着した状態の二層構造を持つ細胞集塊を
形成させることができれば、ヒトの毛球部様構造が再構
築された状態で、育毛や発毛効果を検討可能な細胞培養
素材を提供可能であることを見出し、本発明を完成し
た。
Means for Solving the Problems The present inventor has a new cell culture material capable of providing a new means for evaluating a hair-growth agent and a new means for screening a hair-related drug while keeping the hair growth mechanism in mind. We repeatedly studied about. As a result, if it is possible to form a cell clump having a two-layer structure in which epithelial cells are cell-adhered by cell sorting around the cell clump of hair follicle mesenchymal cells, human hair bulb-like The present invention has been completed by finding that it is possible to provide a cell culture material capable of examining hair growth and hair growth effects in a state where the structure is reconstructed.

【0010】すなわち、本発明は、毛包間葉系細胞の細
胞集塊の外側に、上皮系細胞が細胞接着している、人工
毛球部(以下、本人工毛球部ともいう)を提供すると共
に、本人工毛球部を用いて、養毛作用等を有する、毛髪
に作用する薬剤を評価する方法をも提供する発明であ
る。
That is, the present invention provides an artificial hair bulb portion (hereinafter also referred to as the present artificial hair bulb portion) in which epithelial cells are cell-adhered to the outer side of the cell cluster of hair follicle mesenchymal cells. In addition, the present invention provides a method for evaluating a drug acting on hair, which has a hair-feeding effect and the like, using the present artificial hair bulb part.

【0011】なお、上記の細胞選別とは、多細胞生物の
異なった組織や器官の細胞を解離して単一細胞とし、こ
れを混合した細胞浮遊液の中で再構成を行うと、同じ種
類の細胞同士は接着するが、異なった種類の細胞同士は
接着せずに、凝集塊の中で別々の組織構造を再形成する
現象のことを意味する。
The above-mentioned cell selection means that cells of different tissues or organs of a multicellular organism are dissociated into single cells and reconstituted in a mixed cell suspension to obtain the same kind of cells. Cells adhere to each other, but cells of different types do not adhere to each other, and a different tissue structure is reformed in the aggregate.

【0012】[0012]

【発明の実施の形態】以下、本発明の実施の形態につい
て説明する。 A.本人工毛球部 上述のように、本人工毛球部は、毛包間葉系細胞の細胞
集塊の外側に、上皮系細胞が細胞接着している人工毛球
部である。この本人工毛球部は、毛包間葉系細胞の細胞
集塊の外側に、細胞選別によって上皮系細胞が細胞接着
した状態の二層構造を持つ細胞集塊を形成させて、毛球
部様構造を再構築することにより形成され得る人工毛球
部である。
BEST MODE FOR CARRYING OUT THE INVENTION Embodiments of the present invention will be described below. A. The present artificial hair bulb portion As described above, the present artificial hair bulb portion is an artificial hair bulb portion in which epithelial cells are cell-adhered to the outside of the cell clump of hair follicle mesenchymal cells. This artificial hair bulb portion forms a cell aggregate having a two-layer structure in which epithelial cells are cell-adhered by cell sorting on the outside of the cell aggregate of hair follicle mesenchymal cells, and It is an artificial hair bulb part that can be formed by reconstructing such a structure.

【0013】上皮系細胞としては、典型的には、外毛根
鞘細胞(以下、ORScということもある)を挙げるこ
とができるが、毛芽細胞、マトリックス細胞、ジャーミ
ネイティブ細胞、表皮角化細胞等であってもよい。ま
た、毛包間葉系細胞としては、典型的には毛乳頭細胞
(以下、DPcということもある)であるが、結合織毛
根鞘細胞等であっても良い。
The epithelial cells typically include outer root sheath cells (hereinafter sometimes referred to as ORSc), but hair blast cells, matrix cells, germ native cells, epidermal keratinocytes And so on. The hair follicle mesenchymal cells are typically dermal papilla cells (hereinafter, sometimes referred to as DPc), but may be connective hair root sheath cells and the like.

【0014】本人工毛球部が、毛包間葉系細胞の細胞集
塊が、上皮系細胞により包埋された状態で、毛包間葉系
細胞の細胞集塊の外側に、上皮系細胞が細胞接着してい
る、二層構造の細胞集塊としての態様であることが、よ
り現実の毛根部の構造に準じた状態であり、好適であ
る。
In this artificial hair bulb, the cell aggregates of hair follicle mesenchymal cells are embedded in the epithelial cells, and the epithelial cells are placed outside the cell aggregates of the hair follicle mesenchymal cells. It is preferable that the cells are adhered to each other as a cell aggregate having a two-layer structure, which is in a state more conforming to the actual structure of the hair root part.

【0015】また、細胞外マトリックス構成成分で処理
(主に、細胞外マトリックス構成成分と毛包間葉系細胞
と上皮系細胞を接触させる処理)した毛包間葉系細胞と
上皮系細胞を用いた場合、あるいは、本人工毛球部製造
時の培養液中に細胞外マトリックス構成成分を添加して
製造した本人工毛球部を用いて被験薬剤の評価を行う
と、薬剤に対する反応感度が鋭敏になる傾向が認めら
れ、好適である。
In addition, hair follicle mesenchymal cells and epithelial cells treated with extracellular matrix constituents (mainly, treatment of contacting extracellular matrix constituents with hair follicle mesenchymal cells and epithelial cells) are used. Or the test drug was evaluated using the artificial hair bulb part produced by adding extracellular matrix constituents to the culture solution at the time of manufacturing the artificial hair bulb part, the reaction sensitivity to the drug was sharp. It is preferable because it tends to become.

【0016】この細胞外マトリクス構成成分としては、
例えば、コラーゲン、エラスチン、プロテオグリカン、
グリコサミノグリカン、糖タンパク質等を挙げることが
できるが、特に、現実の毛根部に準じた細胞外マトリク
ス構成成分である、コラーゲンタイプI、IVおよびデル
マタン硫酸を選択することが好適である。
The extracellular matrix constituents include
For example, collagen, elastin, proteoglycan,
Although glycosaminoglycan, glycoprotein, etc. can be mentioned, it is particularly preferable to select collagen types I and IV and dermatan sulfate, which are extracellular matrix constituents conforming to actual hair roots.

【0017】本人工毛球部は、毛包間葉系細胞と上皮系
細胞の共存培養下で、細胞選別によって、毛包間葉系細
胞細胞集塊の周りに上皮系細胞が細胞接着した状態の二
層構造を持つ細胞集塊であり、毛球部様構造が再構築さ
れていることを特徴とする。
The artificial hair bulb part is a state in which epithelial cells are cell-adhered around the hair follicle mesenchymal cell aggregates by cell sorting under co-culture of hair follicle mesenchymal cells and epithelial cells. It is a cell clump having a two-layer structure of and is characterized in that the hair bulb-like structure is reconstructed.

【0018】本人工毛球部は、調製後、そのまま利用す
ることも可能であり、凍結保存して、用時に解凍して利
用することも可能である。本人工毛球部は、被験薬剤の
毛髪に対する効果をスクリーニングするための生体モデ
ルとして用いることができる(これについては後述す
る)。
The artificial hair bulb part can be used as it is after it is prepared, or it can be frozen and stored and then thawed before use. The artificial hair bulb part can be used as a biological model for screening the effect of a test drug on hair (this will be described later).

【0019】また、例えば、本人工毛球部と血管内皮細
胞との関連性を検討することにより、太毛(硬毛)の毛
乳頭内部への血管新生の作用機序を、毛乳頭における内
因性物質等と関連させて検討することが可能であり、こ
の知見により、本人工毛球部を、太毛化(産毛→硬毛)
薬剤の検索手段に用いることもできる。また、本人工毛
球部とメラノサイトとの関連性を検討することにより、
白髪の発生機序について、毛乳頭における内因性物質と
関連させて検討することが可能であり、この知見によ
り、抗白髪剤の検索手段に用いることもできる。また、
本人工毛球部と脂肪細胞との関連性を、毛乳頭における
内因性物質と関連させて検討することにより、毛包の毛
球部が脂肪組織中に深く貫入し、太毛化する作用機所を
検討することが可能であり、この知見により、太毛化
(産毛→硬毛)薬剤の検索手段に用いることもできる。
また、本人工毛球部を、動物の皮膚に移植して、毛包を
誘導させることにより、in vivo の試験をヒトに頼らず
に行うことも可能である。また、組織学的、遺伝子工学
的手法によって、細胞間相互作用やその関連因子の検討
に用いることも可能である。
Further, for example, by examining the relationship between the artificial hair bulb part and vascular endothelial cells, the mechanism of angiogenesis in the dermal papilla of the thick hair (cilia) was determined by the intrinsic factor in the dermal papilla. It is possible to study in association with active substances, etc., and based on this finding, this artificial hair bulb part is made thicker (hair loss → bristles)
It can also be used as a drug search means. Also, by examining the relationship between this artificial hair bulb and melanocytes,
It is possible to study the mechanism of gray hair development in relation to the endogenous substances in the papillae, and based on this finding, it can be used as a means for searching anti-hair graying agents. Also,
By examining the relationship between the artificial hair bulb and adipocytes in relation to the endogenous substances in the papilla of the hair, the mechanism by which the hair bulb of the hair follicle penetrates deep into adipose tissue and becomes thick It is possible to study the location, and based on this finding, it can also be used as a means for searching for agents for thickening hair (hair growth → terminal hair).
It is also possible to perform the in vivo test without relying on humans by implanting the artificial hair bulb part on the skin of animals and inducing hair follicles. In addition, it can be used for the examination of cell-cell interaction and its related factors by histological and genetic engineering techniques.

【0020】このように、本発明は、本人工毛球部にお
ける内因性の物質に関する現象を、その内因性の物質が
関わるべき毛髪における現象と関連付けて、毛髪に関連
する内因性の物質を見出す、養毛物質等を有する毛髪関
連物質の検索方法を提供する発明であり、また、人工毛
球部、および、他の細胞種若しくは組織との共存下にお
いて、人工毛球部における内因性の物質に関する現象
を、その内因性の物質が関わるべき毛髪における現象と
関連付けて、養毛作用等を有する毛髪に関連する内因性
の物質(養毛作用を有する物質等)を見出す、毛髪関連
物質の検索方法を提供する発明である。
As described above, the present invention finds an endogenous substance related to hair by associating the phenomenon related to the endogenous substance in the artificial hair bulb portion with the phenomenon related to the hair to which the endogenous substance is concerned. , An invention that provides a method for searching a hair-related substance having a hair nourishing substance, etc., and an endogenous substance in the artificial hair bulb portion in the coexistence with the artificial hair bulb portion and other cell types or tissues. Of hair-related substances by finding a substance related to hair having a hair nourishing action (a substance having a hair nourishing action, etc.) by associating the phenomenon related to hair with a phenomenon in hair to which the endogenous substance should be related It is an invention that provides a method.

【0021】これらの検索方法の一つは、いいかえれ
ば、本人工毛球部における内因性物質を検出することを
特徴とする、本人工毛球部の使用方法であり、この使用
方法により、人工毛球部における内因性の物質(養毛作
用を有する物質等)に関する現象を、その内因性の物質
が関わるべき毛髪における現象と関連付けて、毛髪に関
連する内因性の物質を見出すことができる。
One of these retrieval methods is, in other words, a method of using the present artificial hair bulb portion, which is characterized by detecting an endogenous substance in the present artificial hair bulb portion. An endogenous substance related to hair can be found by associating a phenomenon related to an endogenous substance (a substance having a hair-feeding action) in the hair bulb part with a phenomenon in hair to which the endogenous substance should be related.

【0022】また、他の一つは、いいかえれば、本人工
毛球部、および、他の細胞種若しくは組織との共存下に
おいて、人工毛球部における内因性物質を検出すること
を特徴とする、本人工毛球部の使用方法であり、この使
用方法により、人工毛球部における内因性の物質(養毛
作用を有する物質等)に関する現象を、その内因性の物
質が関わるべき毛髪における現象と関連付けて、毛髪に
関連する内因性の物質を見出すことができる。
The other one is, in other words, characterized by detecting an endogenous substance in the artificial hair bulb portion in the coexistence with the present artificial hair bulb portion and other cell types or tissues. , This is a method of using the artificial hair bulb part, and by this use method, a phenomenon related to an endogenous substance (a substance having a hair-feeding effect) in the artificial hair bulb portion is described as a phenomenon in the hair to which the endogenous substance should be related. In association with, one can find endogenous substances associated with hair.

【0023】B.本製造方法 本人工毛球部は、毛包間葉系細胞と上皮系細胞とを培養
環境において、共存させて自ら細胞選別させて、毛球部
様構造を再構築することにより製造することができる
(以下、この製造方法を、本製造方法ともいい、特に断
わらない限り、後述する2ステップ法と1ステップ法の
両者を含む概念として用いる)。
B. The present production method The present artificial hair bulb portion can be produced by coexisting hair follicle mesenchymal cells and epithelial cells in a culture environment, allowing the cells to be selected by themselves, and reconstructing a hair bulb-like structure. (Hereinafter, this manufacturing method is also referred to as the present manufacturing method, and unless otherwise specified, it is used as a concept including both a two-step method and a one-step method described later).

【0024】本製造方法は、培養環境において、まず、
毛包間葉系細胞の細胞集塊を形成させた後に、さらに上
皮系細胞を播種して共存培養を行うことによって、この
毛包間葉系細胞の細胞集塊の外側に上皮系細胞が細胞接
着した二層構造の細胞集塊を形成し、毛球部様構造を再
構築した、本人工毛球部を製造する方法が、一態様とし
て挙げられる(この方法を、2ステップ法ともいう)。
This production method is as follows:
After forming a cell clump of hair follicle mesenchymal cells, by further inoculating the epithelial cells and performing co-culture, the epithelial cells are formed outside the cell clumps of the hair follicle mesenchymal cells. As one aspect, a method for producing the present artificial hair bulb part, in which adherent two-layer structure cell aggregates are formed and a hair bulb part-like structure is reconstructed, is mentioned as one aspect (this method is also called a two-step method). .

【0025】すなわち、本製造方法のうち、2ステップ
法は、培養液中(通常は、培養液を満たした培養器の培
養部中である)において、毛包間葉系細胞の細胞集塊を
形成させ、次いで、この細胞集塊と上皮系細胞を、培養
液中で共存させて、細胞選別現象により、毛包間葉系細
胞の細胞集塊の周囲に上皮系細胞を細胞接着させること
により、毛包間葉系細胞の細胞集塊の外側に上皮系細胞
が細胞接着している人工毛球部を製造する、人工毛球部
の製造方法として提供される。
That is, in the two-step method of the present production method, the cell agglomeration of hair follicle mesenchymal cells is performed in the culture medium (usually in the culture section of the incubator filled with the culture medium). Then, the cell clumps and the epithelial cells are allowed to coexist in a culture medium, and the epithelial cells are attached to the cells around the hair clumps of the hair follicle mesenchymal cells by a cell sorting phenomenon. The present invention provides a method for producing an artificial hair bulb part, which comprises producing an artificial hair bulb part in which epithelial cells are cell-adhered to the outside of a cell clump of hair follicle mesenchymal cells.

【0026】また、本製造方法として、培養環境におい
て、毛包間葉系細胞と上皮系細胞をはじめから共存させ
た状態で、培養することにより、上記毛球部様構造の再
構築を行い、本人工毛球部を製造する方法も、他の態様
として挙げられる(この方法を、1ステップ法ともい
う)。
In the present production method, hair follicle mesenchymal cells and epithelial cells are allowed to coexist from the beginning in a culture environment, and the cells are cultured to reconstruct the hair bulb-like structure. The method for producing the present artificial hair bulb part can also be mentioned as another aspect (this method is also referred to as a one-step method).

【0027】すなわち、本製造方法のうち、1ステップ
法は、培養液中(通常は、培養液を満たした培養器の培
養部中である)において、毛包間葉系細胞と上皮系細胞
とを共存させて、細胞選別現象により、毛包間葉系細胞
の細胞集塊を形成させると共に、この細胞集塊の周囲に
上皮系細胞を細胞接着させることにより、毛包間葉系細
胞の細胞集塊の外側に上皮系細胞が細胞接着している人
工毛球部を製造する、人工毛球部の製造方法として提供
される。
That is, in the present production method, the one-step method is the one in which the hair follicle mesenchymal cells and the epithelial cells are placed in the culture medium (usually in the culture section of the incubator filled with the culture medium). Coexisting with each other to form a cell clump of hair follicle mesenchymal cells by a cell sorting phenomenon, and by adhering epithelial cells around the cell clumps, cells of hair follicle mesenchymal cells The present invention is provided as a method for producing an artificial hair bulb portion, which comprises producing an artificial hair bulb portion in which epithelial cells are cell-adhered to the outside of the aggregate.

【0028】本製造方法に用いる毛包間葉系細胞および
上皮系細胞の提供源は、哺乳動物一般から選択すること
が可能であるが、通常の抗白髪薬剤や育毛剤などの毛髪
に作用する薬剤は、ヒトを対象とするものであるから、
ヒトの毛髪の毛包間葉系細胞および上皮系細胞であるこ
とが一般的であり、かつ、好適である。
The source of hair follicle mesenchymal cells and epithelial cells used in the present production method can be selected from mammals in general, but it acts on hair such as ordinary anti-hair graying agents and hair growth agents. Since the drug is intended for humans,
It is common and preferred to be hair follicle mesenchymal cells and epithelial cells of human hair.

【0029】また、毛包間葉系細胞および上皮系細胞
は、通常は、培養細胞の形態で、本製造方法において用
いられ、これらの培養細胞は、常法により得ることがで
きる。例えば、毛包間葉系細胞および上皮系細胞は、美
容外科手術の副産物として得られた毛包を含むヒトの頭
皮から採取することも可能であり、実体顕微鏡下で単離
した毛周期における成長期毛包より採取することも可能
である。
Hair follicle mesenchymal cells and epithelial cells are usually used in the present production method in the form of cultured cells, and these cultured cells can be obtained by a conventional method. For example, hair follicle mesenchymal cells and epithelial cells can also be obtained from human scalp containing hair follicles obtained as a by-product of cosmetic surgery, and growth in hair cycle isolated under a stereomicroscope. It is also possible to collect from the hair follicles.

【0030】まず、本製造方法において用いられる培養
器は、特に限定されないが、静置あるいは旋回培養され
た細胞が、自ら細胞集塊を作りやすい形態および材質の
ものを選択することが好ましい。一般的には、自然重力
によって、細胞が一か所に集中しやすい形状の底面、具
体的には、例えば、丸底型又はすり鉢型等の形状の底面
を有するウエルを培養部として有する培養器が好適であ
る。また、かかる培養部のウエル面に細胞接着防止用の
コーティング処理が施されていることが、特に、好適で
ある。培養部の材質は、通常の細胞培養を行う培養部に
用いられる材質、例えば、プラスチックやガラス等を用
いることが可能であり、特に、限定されるものではな
い。現在、細胞集塊の調製に適した培養プレート〔例え
ば、スミロンセルタイト スフェロイド96Uプレート
(Sumitomo Bakelit co., 製)等が、本製造方法を行う
のに好適な培養器として挙げられる〕が、市販品として
入手可能であるが、本目的に合致するものであれば、こ
れに限定されるわけではない。
First, the incubator used in the present production method is not particularly limited, but it is preferable to select a cell having a form and a material that allow the cells that have been statically or swirl cultured to easily form cell agglomerates. Generally, an incubator having a well having a bottom surface having a shape where cells are easily concentrated in one place by natural gravity, specifically, a well having a bottom shape such as a round bottom type or a mortar type, as a culture section. Is preferred. Further, it is particularly preferable that the well surface of the culture section is subjected to a coating treatment for preventing cell adhesion. The material of the culture section may be the material used in the culture section for performing normal cell culture, for example, plastic or glass, and is not particularly limited. At present, a culture plate suitable for the preparation of cell clumps (for example, Sumiron Celtite spheroid 96U plate (manufactured by Sumitomo Bakelit co., Etc. is mentioned as a suitable incubator for carrying out the present production method) is commercially available. Although it is available as a product, it is not limited to this as long as it meets the purpose.

【0031】また、培養液は、ヒト由来の細胞を培養す
ることが可能なものであれば、特に限定されず、培養の
態様に応じて、既知の培地を適宜選択して用いたり、適
宜改変して用いることができる。既知の培地としては、
例えば、DMEM(GibcoBRL:11965-092)、Keratinocyte
-SFM (GibcoBRL:11965-011) 、William's E(GibcoBRL:
74N4752)等を挙げることができる。
The culture medium is not particularly limited as long as it is capable of culturing cells of human origin, and a known medium is appropriately selected and used or appropriately modified according to the mode of culture. Can be used. Known media include:
For example, DMEM (GibcoBRL: 11965-092), Keratinocyte
-SFM (GibcoBRL: 11965-011), William's E (GibcoBRL:
74N4752) and the like.

【0032】2ステップ法 2ステップ法においては、まず、培養環境において、毛
包間葉系細胞の細胞集塊を形成させる工程を行う。
Two-Step Method In the two-step method, first, a step of forming a cell clump of hair follicle mesenchymal cells in a culture environment is performed.

【0033】好適には、細胞集塊の調製に適した培養プ
レートの各ウエルの中に、上述の毛包間葉系細胞を再分
散させた培養液を入れ、これをインキュベートすること
により、所望する毛包間葉系細胞の細胞集塊を得ること
ができる。
Preferably, a culture solution in which the above-mentioned hair follicle mesenchymal cells are redispersed is put into each well of a culture plate suitable for preparation of cell clumps, and this is incubated to obtain the desired mixture. A cell aggregate of hair follicle mesenchymal cells can be obtained.

【0034】各ウエルに播種する毛包間葉系細胞の細胞
数は、好適には100 〜5000Cells 程度、特に好適には、
500 〜4000Cells 程度である。細胞数が、100Cells未満
であると、本人工毛球部に用いる十分な大きさの細胞集
塊が形成されず、5000Cellsを超えると、細胞集塊中心
部で壊死が起こり、好ましくない。また、産毛から終毛
を含めた現実の頭髪毛球部の大きさを考慮すると、毛包
間葉系細胞数は、各ウエル当り、100 〜5000Cells 程度
とすることが好適である。
The number of hair follicle mesenchymal cells seeded in each well is preferably about 100 to 5000 cells, and particularly preferably,
It is about 500 to 4000 cells. If the number of cells is less than 100 Cells, a cell aggregate having a size large enough to be used in the present artificial hair bulb portion is not formed, and if it exceeds 5000 Cells, necrosis occurs in the center portion of the cell aggregate, which is not preferable. Further, in consideration of the actual size of the hair bulb part including the hairs from the nap to the hair ends, it is preferable that the number of hair follicle mesenchymal cells is about 100 to 5000 cells per well.

【0035】また、インキュベートは、一般的な哺乳動
物の細胞を培養する条件、具体的には、32〜42℃程度
で、5%程度のCO2 下で、静置培養あるいは旋回培養
することによりインキュベートを行うことができる。こ
のインキュベートは、十分に毛包間葉系細胞の細胞集塊
が形成されるまで行うのが好適であり、概ね24時間程
度で完了させることができる。
The incubation is carried out under the conditions for culturing general mammalian cells, specifically, by static culture or swirling culture at about 32-42 ° C. under about 5% CO 2. Incubation can be performed. This incubation is preferably performed until a cell clump of hair follicle mesenchymal cells is sufficiently formed, and can be completed in about 24 hours.

【0036】2ステップ法では、次に、この毛包間葉系
細胞の細胞集塊に対して、上皮系細胞を共存させてイン
キュベートすることにより、毛球部様構造の再構築を行
い、本人工毛球部を製造する工程を行う。
In the two-step method, the epithelial cells are allowed to co-incubate with the cell clumps of the hair follicle mesenchymal cells, and the hair bulb-like structure is reconstructed by A step of manufacturing the artificial hair bulb portion is performed.

【0037】この工程は、上記の工程により毛包間葉系
細胞の細胞集塊が形成された培養物に、培養液中に再分
散させた上皮系細胞を播種して、毛包間葉系細胞と上皮
系細胞を共存させて、インキュベートすることにより行
うことができる。
In this step, the culture in which the cell aggregates of hair follicle mesenchymal cells have been formed by the above-mentioned step is seeded with the epithelial cells redispersed in the culture solution to obtain the hair follicle mesenchymal cells. It can be performed by allowing cells and epithelial cells to coexist and incubating.

【0038】各ウエルに播種する上皮系細胞の細胞数
は、好適には100 〜5000Cells 程度、特に好適には、50
0 〜4000Cells 程度である。細胞数が、100Cells未満で
あると、毛包間葉系細胞の細胞集塊の周囲に十分に上皮
系細胞が付着せず、5000Cellsを超えると、上皮系細胞
層の厚みが厚くなり過ぎ、中心部の細胞が壊死するの
で、好ましくない。また、現実の毛球部の大きさを考慮
すると、上皮細胞数は、各ウエル当り、100 〜5000Cell
s 程度であり、かつ、毛包間葉系細胞数に対して、同数
程度とすることが好適である。
The number of epithelial cells seeded in each well is preferably about 100 to 5000 cells, and particularly preferably 50.
It is about 0 to 4000 cells. If the number of cells is less than 100 Cells, the epithelial cells do not adhere sufficiently around the cell aggregates of hair follicle mesenchymal cells, and if it exceeds 5000 Cells, the thickness of the epithelial cell layer becomes too thick, This is not preferable because some cells are necrotic. In consideration of the actual size of the hair bulb, the number of epithelial cells is 100 to 5000 cells per well.
It is preferable that the number is about s, and about the same as the number of hair follicle mesenchymal cells.

【0039】また、この工程のインキュベートは、上記
の毛包間葉系細胞の細胞集塊を調製する工程における培
養条件と同様の条件で行うことが可能であり、上皮系細
胞の添加後、概ね48時間程度で完了させることができ
る。
The incubation in this step can be carried out under the same conditions as the culture conditions in the step of preparing the cell clumps of hair follicle mesenchymal cells described above. It can be completed in about 48 hours.

【0040】このように、毛包間葉系細胞の細胞集塊と
分散した状態の上皮系細胞を共存させた状態でインキュ
ベートすることにより、上皮系細胞が、毛包間葉系細胞
の細胞集塊の周囲に細胞接着した状態で細胞選別され、
その結果、二層構造を持つ細胞集塊である本人工毛球部
を製造することができる。
In this way, by incubating the hair clumps of hair follicle mesenchymal cells and the dispersed epithelial cells in the coexisting state, the epithelial cells become a collection of hair follicle mesenchymal cells. The cells are sorted in the state that they adhere to the cells around the mass,
As a result, the present artificial hair bulb part, which is a cell aggregate having a two-layer structure, can be manufactured.

【0041】1ステップ法 1ステップ法は、培養液を満たした培養器の培養部中に
おいて、毛包間葉系細胞と上皮系細胞とを播種して共存
させ、これをインキュベートすることにより行われる。
One-step method The one-step method is carried out by inoculating and coexisting hair follicle mesenchymal cells and epithelial cells in a culture part of a culture vessel filled with a culture solution, and incubating these. .

【0042】すなわち、毛包間葉系細胞と上皮系細胞
は、混合後、好適には、培養液中に分散させた状態で、
細胞集塊の調製に適した培養プレートのウエルの中に、
添加して、これを培養することにより、1ステップ法の
インキュベートを行うことができる。
That is, the hair follicle mesenchymal cells and the epithelial cells are preferably mixed in a culture medium after mixing,
In the well of the culture plate suitable for the preparation of cell clumps,
By adding and culturing this, one-step method of incubation can be performed.

【0043】分散させた毛包間葉系細胞と上皮系細胞の
細胞数は、2ステップ法において示した条件と同様の条
件で行うことができる。また、毛包間葉系細胞と上皮系
細胞の1培養物当りの混合割合は、上皮系細胞数が毛包
間葉系細胞数に対して、同数程度とすることが好適であ
る。
The number of dispersed hair follicle mesenchymal cells and epithelial cells can be determined under the same conditions as those shown in the two-step method. The mixing ratio of hair follicle mesenchymal cells and epithelial cells per culture is preferably about the same as the number of epithelial cells to the number of hair follicle mesenchymal cells.

【0044】また、インキュベートは、一般的な哺乳動
物の細胞を培養する条件、具体的には、32〜42℃程度
で、5%程度のCO2 下で、静置あるいは旋回培養する
ことによりインキュベートを行うことができる。このイ
ンキュベートは、概ね48から72時間程度で完了させ
ることができる。
The incubation is carried out by culturing the cells under ordinary conditions, specifically, at 32 to 42 ° C. under CO 2 of about 5% by static or culturing. It can be performed. This incubation can be completed in about 48 to 72 hours.

【0045】このように、分散した状態の毛包間葉系細
胞と上皮系細胞を共存させた状態でインキュベートする
ことにより、毛包間葉系細胞の細胞集塊の形成が行われ
ると同時に、上皮系細胞が、この毛包間葉系細胞の細胞
集塊の周囲に細胞接着した状態で細胞選別され、二層構
造を持つ細胞集塊である本人工毛球部を製造することが
できる。
As described above, by incubating the dispersed hair follicle mesenchymal cells and the epithelial cells in the coexisting state, the formation of cell aggregates of the hair follicle mesenchymal cells is performed at the same time. The epithelial cells are cell-sorted in a state of being cell-adhered around the cell aggregates of the hair follicle mesenchymal cells, and the present artificial hair bulb part, which is a cell aggregate having a bilayer structure, can be produced.

【0046】また、本人工毛球部の製造過程において、
細胞外マトリクス構成成分を単独または複数含む培養液
で37℃、10分間処理した毛包間葉系細胞と上皮系細胞を
用いるか、あるいは、通常の培養液の替わりに、細胞外
マトリクス構成成分を単独または複数含む培養液を用い
ることができる。培養液中の細胞外マトリックス構成成
分の濃度は、物質によって最適濃度が異なるが、概ね、
培養液に対して0.00001 〜1 質量%の範囲で添加するこ
とができる。
In the process of manufacturing the artificial hair bulb,
Use hair follicle mesenchymal cells and epithelial cells that have been treated with a culture medium containing one or more extracellular matrix components at 37 ° C for 10 minutes, or use extracellular matrix components instead of the usual culture medium. A single or a plurality of culture solutions can be used. Regarding the concentration of extracellular matrix constituents in the culture solution, the optimum concentration varies depending on the substance, but in general,
It can be added in the range of 0.00001 to 1 mass% with respect to the culture solution.

【0047】このようにして、細胞外マトリクス構成成
分で処理した細胞、あるいは細胞外マトリクス構成成分
存在下で人工毛球部を製造する、本製造方法が提供され
る。 C.本評価方法等 本発明は、本人工毛球部に対して被験薬剤を作用させた
場合の人工毛球部における現象を、被験薬剤の毛髪に対
する作用と関連付けて、毛髪に対する作用(育毛作用
等)を有する被験薬剤を評価する、被験薬剤の評価方法
を提供し、さらに、本人工毛球部、および、他の細胞種
若しくは組織との共存下で、被験薬剤を作用させた場合
の人工毛球部における現象を、被験薬剤の毛髪に対する
作用と関連付けて、毛髪に対する作用(育毛作用等)を
有する被験薬剤を評価する、被験薬剤の評価方法を提供
する発明である(これらの発明を、以下、共に、本評価
方法ともいう)。
In this way, there is provided the present production method for producing cells treated with an extracellular matrix constituent or an artificial hair bulb in the presence of an extracellular matrix constituent. C. The present evaluation method, etc. The present invention relates the phenomenon in the artificial hair bulb part when the test drug is made to act on the present artificial hair bulb part, in association with the effect of the test drug on the hair, and the effect on the hair (hair growth effect etc.) To provide a method for evaluating a test drug, which further comprises the present artificial hair bulb part, and an artificial hair ball when the test drug is allowed to act in the coexistence with other artificial cell types or tissues. It is an invention that provides a method for evaluating a test drug, which evaluates a test drug having an action on hair (hair-growth action, etc.) by associating a phenomenon in the part with the action of the test drug on hair (these inventions are Both are also called this evaluation method).

【0048】なお、本評価方法の一つは、いいかえる
と、本人工毛球部に対して被験薬剤を作用させることを
特徴とする、本人工毛球部の使用方法(本使用方法1と
もいう)であり、この使用方法を行うことにより、人工
毛球部における現象と、被験薬剤(育毛剤等)の毛髪に
対する作用との関連付けが可能となり、被験薬剤の評価
を行うことができる。
In addition, one of the evaluation methods is, in other words, a method of using the present artificial hair bulb part, which is characterized in that a test drug is allowed to act on the present artificial hair bulb part (also referred to as the present usage method 1). By performing this method of use, it becomes possible to associate the phenomenon in the artificial hair bulb portion with the action of the test drug (hair-growth agent, etc.) on the hair, and it is possible to evaluate the test drug.

【0049】また、本評価方法の他の一つは、いいかえ
ると、本人工毛球部を、他の細胞種若しくは組織との共
存下で、被験薬剤を作用させることを特徴とする、本人
工毛球部の使用方法(本使用方法2ともいう)であり、
この使用方法を行うことにより、人工毛球部における現
象と、被験薬剤の毛髪に対する作用との関連付けが可能
となり、被験薬剤(育毛剤等)の評価を行うことができ
る。
In addition, another one of the present evaluation methods is, in other words, that the test drug is allowed to act on the artificial hair bulb part in the coexistence with other cell types or tissues. How to use the hair bulb part (also called this usage method 2),
By performing this method of use, it becomes possible to associate the phenomenon in the artificial hair bulb portion with the action of the test drug on the hair, and it is possible to evaluate the test drug (hair growth agent etc.).

【0050】本評価方法は、このような本人工毛球部の
生体モデルとしての、特に好適な態様の一つである。本
評価方法において選択可能な被験薬剤の毛髪に対する作
用は、特に限定されず、発毛誘導作用、毛髪の成長期の
延長作用等の育毛作用は勿論のこと、脱毛作用を有する
被験薬剤や抗白髪作用を有する被験薬剤も、本評価方法
を用いて、invitroで選択することができる。また、被
験薬剤は、例えば、上記の本人工毛球部の製造工程の終
了後、直ちに、培養系に添加して本評価方法を行うこと
も可能であり、一旦、冷凍保存した本人工毛球部を、一
般的な凍結細胞における解凍法に従い解凍して、これに
被験薬剤を作用させることも可能である。
The present evaluation method is one of the particularly preferable modes as a biological model of the present artificial hair bulb part. The action of the test drug that can be selected in this evaluation method on hair is not particularly limited, and not only the hair-growth-inducing action, the hair-growth action such as the extension action of the hair growth period, and the test drug having anti-hair loss action or anti-hair graying A test drug having an action can also be selected in vitro using this evaluation method. Further, the test drug can be added to the culture system immediately after the production process of the artificial hair bulb part described above to perform the present evaluation method. It is also possible that the part is thawed according to a general thawing method for frozen cells and the test drug is allowed to act on it.

【0051】被験薬剤の人工毛球部における現象と、毛
髪に対する作用を関連付ける手段は、選択対象となる被
験薬剤の作用に応じて選択を行うことができ、例えば、
培養学的、生化学的、組織学的、遺伝子工学的、免疫学
的手法など各種検出手段を用いることが可能である。
The means for associating the phenomenon of the test drug in the artificial hair bulb portion with the action on the hair can be selected according to the action of the test drug to be selected.
It is possible to use various detection means such as culture, biochemistry, histology, genetic engineering and immunological techniques.

【0052】例えば、選択対象となる被験薬剤の作用
が、発毛誘導作用の場合には、人工毛球部における呼吸
量の増加(アラマーブルーを用いる方法等により検出可
能)、DNA 量の増加、PCNA量の増加、ヴァーシカンやWn
t mRNA量の発現量の増加(RT−PCR法等により
検出可能)等を挙げることができる。
For example, when the action of the test drug to be selected is a hair growth-inducing action, an increase in respiration in the artificial hair bulb (detectable by a method using Alamar Blue), an increase in DNA amount , Increase in PCNA amount, Vasikan or Wn
Examples thereof include an increase in the expression amount of t mRNA (which can be detected by RT-PCR or the like).

【0053】また、選択対象となる被験薬剤の作用が、
毛髪の成長期の延長作用の場合には、人工毛球部におけ
るTGF βmRNA量の発現量の減少(RT−PCR法等
により検出可能)等を挙げることができる。
The action of the test drug to be selected is
In the case of the action of prolonging the hair growth phase, there may be mentioned a decrease in the expression level of TGF β mRNA in the artificial hair bulb portion (which can be detected by RT-PCR etc.).

【0054】例えば、本評価方法で、発毛誘導作用を有
する被験薬剤を選択する場合に、通常よりも、本人工毛
球部における呼吸量が増加していれば、人工毛球部の代
謝が亢進していることを意味し、この現象と生体内で休
止状態の休止期毛球部が成長期に移行するとともに代謝
活性が急激に高くなる現象、すなわち、被験薬剤の発毛
誘導作用を関連付けられる。逆に、本人工毛球部におけ
る呼吸量を抑制する被験薬剤は、脱毛作用を有する薬剤
として、本評価方法により選択され得る。
For example, when a test drug having a hair-growth-inducing action is selected by the present evaluation method, if the respiration volume in the artificial hair bulb portion is higher than usual, the metabolism of the artificial hair bulb portion is increased. This phenomenon is associated with the phenomenon in which the resting hair bulb in the resting state in the living body shifts to the growth phase and the metabolic activity sharply increases, that is, the hair growth-inducing effect of the test drug. To be On the contrary, the test drug that suppresses the respiration rate in the present artificial hair bulb part can be selected by the present evaluation method as a drug having a depilatory action.

【0055】このようにして、本評価方法により、毛髪
に対する作用を有する被験薬剤を選択することができ
る。また、本発明は、本評価方法や、それと実質的に同
一の、本使用方法1および2を行うためのキット(以
下、本評価用キットともいう)をも提供する発明であ
る。
In this way, the test drug having an action on hair can be selected by this evaluation method. The present invention also provides the present evaluation method and a kit (hereinafter also referred to as the present evaluation kit) for carrying out the present Usage Methods 1 and 2, which is substantially the same as the present evaluation method.

【0056】すなわち、本評価用キットは、本人工毛球
部を、構成要素として含む、本評価方法または本使用方
法1若しくは2を行うためのキットである。本評価用キ
ットには、本人工毛球部と共に培養器、培養液、添加薬
剤等が含まれ得る。また、細胞外マトリックス構成成分
を構成要素として含めることも可能である。
That is, the present evaluation kit is a kit for carrying out the present evaluation method or the present usage method 1 or 2, which contains the present artificial hair bulb portion as a constituent element. The present evaluation kit may include an incubator, a culture solution, an additive drug, and the like together with the present artificial hair bulb part. It is also possible to include extracellular matrix constituents as constituents.

【0057】[0057]

【実施例】以下、本発明を実施例を用いてさらに具体的
に説明する。初代外毛根鞘培養細胞の調製 ヒトの美容整形手術により入手した頭皮から単離した単
離毛包の毛球部を切除した後、1000unit/ml dispase +
0.2% cllagenase を含む Keratinocyte-SFM 培地(Gibco
BRL:11965-011)中で、37℃で30分間酵素処理した後、注
射針(27G )の先を用いて、結合織毛根鞘などの余分な
毛包間葉系組織を取り除き、コラーゲンコーティングし
た培養器の培養部中に静置して、抗菌剤を含むKeratino
cyte-SFM培地中で、explant culture を行った。培養約
1週間後に細胞の増殖が確認できた時点で、培地を交換
した。サブコンフルエントまで増殖した細胞を、PBS(-)
+0.05%trypsin で37℃で3 分間処理した後、等量以上の
PBS(-)+0.1%trypsin inhibitor(Sigma) で反応を停止さ
せ、遠心分離(1200rpm X 5min)によって細胞を回収し
た。回収した細胞をPBS(-)に再懸濁した後、遠心分離
(1200rpm X 5min)によって、細胞を回収し、細胞の洗
浄を行った。洗浄した細胞をセルバンカーII(ダイアヤ
トロン社:ZCB-201(100))を用いて、液体窒素中で凍結
保存を行い、初代外毛根鞘培養細胞を得た。
EXAMPLES The present invention will be described in more detail below with reference to examples. Preparation of primary outer root sheath cell culture cells 1000 units / ml dispase + after excision of the hair bulb part of the isolated hair follicle isolated from the scalp obtained by human cosmetic surgery
Keratinocyte-SFM medium containing 0.2% cllagenase (Gibco
(BRL: 11965-011), after enzymatic treatment at 37 ° C for 30 minutes, excess hair follicle mesenchymal tissue such as connective woven root sheath was removed using a tip of an injection needle (27G), and collagen coating was performed. Keratino containing the antibacterial agent is left to stand in the culture part of the incubator.
Explant culture was performed in cyte-SFM medium. When cell growth could be confirmed after about 1 week of culture, the medium was replaced. Cells grown to sub-confluence were added to PBS (-)
After treatment with + 0.05% trypsin at 37 ℃ for 3 minutes,
The reaction was stopped with PBS (-) + 0.1% trypsin inhibitor (Sigma), and cells were collected by centrifugation (1200 rpm x 5 min). The collected cells were resuspended in PBS (-), and then the cells were collected by centrifugation (1200 rpm x 5 min) and washed. The washed cells were cryopreserved in liquid nitrogen using Cellbanker II (Diatron Corp .: ZCB-201 (100)) to obtain primary outer root sheath cultured cells.

【0058】初代培養毛乳頭細胞の調製 ヒトの美容整形手術により入手した頭皮から単離した単
離毛包から切除して得た毛球部から、注射針(27G )の
先を用いて、毛乳頭部分を実体顕微鏡下で単離し、コラ
ーゲンコーティングした培養器の培養部中に静置して、
抗菌剤を含む10%FBS添加DMEM培地(GibcoBRL:
11965-092)中で、explant culture を行った。培養約2
週間後に細胞の増殖が確認できた時点で培地を交換し
た。サブコンフルエントまで増殖した細胞を、PBS(-)+
0.05%trypsin で37℃で3分間処理した後、等量以上のP
BS(-)+0.1%trypsin inhibitor(Sigma) で反応を停止さ
せ、遠心分離(1200rpm X 5min)によって細胞を回収し
た。回収した細胞を、PBS(-)に再懸濁した後、遠心分離
(1200rpm X 5min)によって細胞を回収し細胞の洗浄を
行った。洗浄した細胞をセルバンカーII(ダイアヤトロ
ン社:ZCB-201(100))を用いて、液体窒素中で凍結保存
を行い、初代毛乳頭培養細胞を得た。
Preparation of Primary Cultured Hair Papillary Cells From the hair bulb obtained by excision from an isolated hair follicle isolated from the scalp obtained by human cosmetic surgery, the hair was obtained using the tip of an injection needle (27G). The papilla part was isolated under a stereomicroscope and allowed to stand in the culture part of a collagen-coated incubator,
10% FBS-added DMEM medium containing antibacterial agent (GibcoBRL:
11965-092), explant culture was conducted. About 2
The medium was replaced when cell growth could be confirmed after a week. Cells grown to sub-confluence are treated with PBS (-) +
After treatment with 0.05% trypsin at 37 ℃ for 3 minutes, the same amount of P
The reaction was stopped with BS (-) + 0.1% trypsin inhibitor (Sigma), and cells were collected by centrifugation (1200 rpm x 5 min). The collected cells were resuspended in PBS (-), and then the cells were collected by centrifugation (1200 rpm x 5 min) and washed. The washed cells were cryopreserved in liquid nitrogen using Cellbanker II (Zayatron Co., Ltd .: ZCB-201 (100)) to obtain primary dermal papilla cells.

【0059】本人工毛球部の製造 (1)2ステップ法 上記により得られた初代毛乳頭培養細胞を、Type I col
lagen コートした75cm2 培養フラスコ中、10%FB
S添加DMEM(GibcoBRL:11965-092)培地で3回継代培
養(37℃、5%CO2 )し、セルバンカーII(ダイア
ヤトロン社:ZCB-201(100))を用いて、液体窒素中で凍
結保存を行った。
Production of the present artificial hair bulb part (1) Two-step method The primary dermal papilla culture cells obtained as described above were treated with Type I col.
10% FB in a 75 cm 2 culture flask coated with lagen
The cells were subcultured three times (37 ° C., 5% CO 2 ) in an S-containing DMEM (GibcoBRL: 11965-092) medium, and were used in liquid nitrogen using Cellbanker II (Diatron Corp .: ZCB-201 (100)). It was cryopreserved.

【0060】また、上記により得られた初代外毛根鞘細
胞を、Type I collagen コートした75cm2 培養フラス
コ中、Keratinocyte-SFM (GibcoBRL:11965-011) 培地で
3回継代培養(37℃、5%CO2 )し、セルバンカー
II(ダイアヤトロン社:ZCB-201(100))を用いて、液体
窒素中で凍結保存を行った。
The primary outer root sheath cells obtained as described above were subcultured three times in Keratinocyte-SFM (GibcoBRL: 11965-011) medium in a Type I collagen-coated 75 cm 2 culture flask (37 ° C., 5 % CO 2 ) and then cell banker
Using II (Diatron Corp .: ZCB-201 (100)), it was cryopreserved in liquid nitrogen.

【0061】次に、凍結保存したDPcを解凍し、氷冷
したKeratinocyte-SFM培地で洗浄後、同培地の中に再分
散させ、血球計算板を用いて細胞密度を計測した。次い
で、細胞の細胞密度を、5×104Cells/ml に調整し、
得られたDPc懸濁 Keratinocyte SFM(+)培地を40μl
(2 X 103cells/well )を、スミロンセルタイト スフ
ェロイド96Uプレート(Sumitomo Bakelit co., 製)
の各ウエルに播種し、1日間培養した(37℃、5%C
2 )。DPc の細胞集塊が形成されていることを確認
し、凍結保存したORScを解凍後、上記のDPcと同
様に、細胞密度を5×104Cells/ml に調整したORS
c懸濁KeratinocyteSFM(+)培地を40μl(2 X 103cells/
well )を、各ウエルに播種して、さらに1日間培養
(37℃、5%CO2 )を行い、DPcの細胞集塊の周
囲にORScが細胞接着した状態に細胞選別された本人
工毛球部を、2ステップ法で製造した。
Next, the frozen-preserved DPc was thawed, washed with ice-cooled Keratinocyte-SFM medium, redispersed in the same medium, and the cell density was measured using a hemocytometer. Then, the cell density of the cells was adjusted to 5 × 10 4 cells / ml,
40 μl of the obtained DPc suspended Keratinocyte SFM (+) medium
(2 X 10 3 cells / well), Sumiron Celtite Spheroid 96U plate (Sumitomo Bakelit co., Manufactured)
, And cultured for 1 day (37 ° C., 5% C
O 2 ). It was confirmed that a cell clump of DPc was formed, and after the cryopreserved ORSc was thawed, the cell density was adjusted to 5 × 10 4 cells / ml in the same manner as DPc above.
c Suspension Keratinocyte SFM (+) medium 40 μl (2 X 10 3 cells /
wells) are seeded in each well and further cultured for 1 day (37 ° C., 5% CO 2 ). The present artificial hair bulb in which ORSc is cell-adhered around the DPc cell cluster. Parts were made in a two step process.

【0062】(2)1ステップ法 上記(1)と同様に凍結保存したDPcおよびORSc
を解凍し、氷冷したKeratinocyte-SFM培地で洗浄後、Ke
ratinocyteSFM(+)培地に分散させ、血球計算板を用いて
それぞれの細胞密度を計測した。次いで、それぞれの細
胞の細胞密度を、5×104Cells/ml に調整後、氷冷
下、等量ずつ混合した。混合した細胞懸濁Keratinocyte
SFM(+)培地を、80μl ずつ、スミロンセルタイト スフ
ェロイド96Uプレート(Sumitomo Bakelit co., 製)
の各ウエルに播種し、2 日間培養(37℃、5%C
2 )し、DPc の細胞集塊の周囲にORSc が細胞接
着した状態に細胞選別された本人工毛球部を、1ステッ
プ法で製造した。
(2) One-step method DPc and ORSc cryopreserved as in (1) above
Thaw and wash with ice-cold Keratinocyte-SFM medium, then
The cells were dispersed in ratinocyte SFM (+) medium and the cell density of each was measured using a hemocytometer. Then, the cell density of each cell was adjusted to 5 × 10 4 cells / ml, and then mixed in equal amounts under ice cooling. Mixed cell suspension Keratinocyte
80 μl each of SFM (+) medium, Sumiron Celtite spheroid 96U plate (Sumitomo Bakelit co., Manufactured)
Seed in each well and culture for 2 days (37 ℃, 5% C
O 2 ), and the present artificial hair bulb part in which cells were sorted in a state in which ORSc were cell-adhered around the DPc cell cluster was produced by the one-step method.

【0063】(3)単層・単一/共存培養法(比較例) 1ステップあるいは2ステップ法で用いたスミロンセル
タイト スフェロイド96Uプレート(Sumitomo Bakel
it co., 製)の代わりに、一般的なコラーゲンコート平
底96穴マイクロプレートを用い、すべての実験条件は、
2ステップ法および1ステップ法と同様に行った。
(3) Monolayer / Single / Coculture Method (Comparative Example) Sumilon Celtite Spheroid 96U Plate (Sumitomo Bakel) used in the one-step or two-step method
Instead of it), a general collagen-coated flat-bottom 96-well microplate was used, and all experimental conditions were
The procedure was the same as the two-step method and the one-step method.

【0064】(4)本評価方法(呼吸量の変化を指標と
した場合の例) 上記(1)、(2)、(3)で調製した、各培養物に対
して、被験薬剤を含むWilliam's E(+)培地[10 μg/mlト
ランスフェリン、10ng/ml ハイドロコルチゾン、10μg/
mlインスリン、10ng/ml sodium selenite を補充] を、
80μl ずつ添加し、37℃、5%CO2 下で、2日間
さらに培養を行った。
(4) This evaluation method (example in which change in respiratory volume is used as an index) William's containing a test drug was added to each culture prepared in (1), (2) and (3) above. E (+) medium [10 μg / ml transferrin, 10 ng / ml hydrocortisone, 10 μg / ml
Replenish with ml insulin, 10ng / ml sodium selenite],
80 μl of each was added, and the cells were further cultured at 37 ° C. under 5% CO 2 for 2 days.

【0065】培養後、アラマーブルー(Biosource:DAL11
00) 、Keratinocyte-SFM培地、William's E(+)培地を、
それぞれ、2:1:1(容量比)の割合で混合し、37
℃に温めた後、40μl ずつ、各ウエルに添加し、37
℃で6時間の反応を行った。反応終了後、各ウエルから
100μl ずつ反応液を採取し、蛍光測定用白色96穴
プレート(Opaque Plate)(Coster:3912)の各ウエルに
分注した。
After culturing, Alamar Blue (Biosource: DAL11
00), Keratinocyte-SFM medium, William's E (+) medium,
Mix them at a ratio of 2: 1: 1 (volume ratio), 37
After warming to ℃, add 40 μl to each well and
The reaction was conducted at 6 ° C for 6 hours. After the reaction was completed, 100 μl of the reaction solution was collected from each well and dispensed into each well of a white 96-well plate for fluorescence measurement (Opaque Plate) (Coster: 3912).

【0066】各ウエルの蛍光強度を、励起波長544n
m、蛍光波長590nmに設定した、Labsystems Fluorosk
an II(大日本製薬社)で測定し、細胞を培養していな
い反応液(培地そのもの)の蛍光強度を差し引いて、各
条件下での呼吸量を求めた。
The fluorescence intensity of each well was measured at the excitation wavelength of 544n.
Labsystems Fluorosk with m and fluorescence wavelength of 590 nm
The amount of respiration under each condition was obtained by measuring with an II (Dainippon Pharmaceutical Co., Ltd.) and subtracting the fluorescence intensity of the reaction solution (medium itself) in which cells were not cultured.

【0067】相対呼吸量(%)は、下記の計算式により
算出した。 〔呼吸量(被験薬剤)〕/〔呼吸量(陰性コントロー
ル)〕×100(%)本人工毛球部の評価 (1)被験薬剤を含まない場合の評価(第1図)試験方法 :被験薬剤を含まない条件下における、本人
工毛球部の有用性を確認するために、i)上記の1ステ
ップ法と同様の条件で集塊培養を行って得られた毛乳頭
細胞の細胞集塊、ii) 上記の単層培養法と同様の条件で
単層培養を行って得られた毛乳頭細胞の単層培養物(以
上、第1図のDP)、iii)上記の1ステップ法と同様の
条件で集塊培養を行って得られた外毛根鞘細胞の細胞集
塊、iv)上記の単層培養法と同様の条件で単層培養を行
って得られた外毛根鞘細胞の単層培養物(以上、第1図
のORS)、v)1ステップ法を用いて得た、本人工毛球
部、vi) 1ステップ法に準じて得た、比較例の複合培養
物(以上、第1図のDP+ORS)を使用して、被験薬
剤を含まない条件下において、本評価方法〔上記の
(4)に示した本評価方法の実施態様、ただし、被験薬
剤を含まない培地を用いた〕を行い、本人工毛球部と比
較例における呼吸量の違いを比較した。
The relative respiratory volume (%) was calculated by the following formula. [Breathing volume (test drug)] / [Breathing volume (negative control)] x 100 (%) Evaluation of the artificial hair bulb part (1) Evaluation without test drug (Fig. 1) Test method : Test drug In order to confirm the usefulness of the present artificial hair bulb part under conditions not containing: i) cell agglutination of hair papilla cells obtained by performing agglutination culture under the same conditions as in the above 1-step method, ii) A monolayer culture of dermal papilla cells obtained by carrying out a monolayer culture under the same conditions as the above monolayer culture method (above, DP in FIG. 1), iii) the same as the one-step method above Cell aggregation of outer root sheath cells obtained by performing confluent culture under the conditions, iv) Monolayer culture of outer root sheath cells obtained by performing single layer culture under the same conditions as the above monolayer culture method (Above, ORS in FIG. 1), v) the artificial hair bulb part obtained by using the one-step method, vi) the composite of the comparative example obtained according to the one-step method Using the culture (above, DP + ORS in FIG. 1), under the condition that the test drug is not included, the present evaluation method [the embodiment of the present evaluation method shown in (4) above, provided that the test drug is included) Was used, and the difference in respiratory volume between the present artificial hair bulb and the comparative example was compared.

【0068】第1図のグラフにおいて、同一ウエルに播
種した細胞の種類を、縦軸に蛍光強度の実測値を示し
た。また、各棒グラフの左側は単層培養法の、右側は集
塊培養法の結果を示している。
In the graph of FIG. 1, the type of cells seeded in the same well is shown, and the vertical axis shows the measured value of fluorescence intensity. The left side of each bar graph shows the result of the monolayer culture method, and the right side shows the result of the agglutination culture method.

【0069】結果:単層培養したDPc、ORSc、
およびDPcとORScの共存培養での呼吸量は、集塊
培養した場合と比較していずれも高くなっており、特に
DPcを含む培養系ではその差が顕著であった。また、
本人工毛球部の呼吸量は極めて少ないことが明らかとな
った。このことは、本人工毛球部に対して、毛髪に対し
て何らかの作用を及ぼす被験薬剤を接触させた場合、鋭
敏にこれを検出可能であることを示唆している。また、
この呼吸量が少ない状態は、休止期の毛包部の状態に準
じた状態であり、特に、本人工毛球部が、休止期の毛包
部の活動を活性化させる物質の検出に適していることを
示唆している。
Results : Monolayer cultured DPc, ORSc,
The respiration rate in the coculture of DPc and ORSc was higher than that in the case of the agglutination culture, and the difference was remarkable especially in the culture system containing DPc. Also,
It was revealed that the artificial hair bulb had a very small respiration rate. This suggests that when the test agent which has some effect on hair is brought into contact with the present artificial hair bulb portion, this can be detected sensitively. Also,
This state of low respiration volume is in accordance with the state of hair follicles in the resting period, and this artificial hair bulb is particularly suitable for detecting substances that activate the activity of the hair follicles in the resting period. Suggesting that

【0070】(2)被験薬剤を用いた評価(第2図) さらに、本人工毛球部の鋭敏性について検討するため
に、公知の発毛促進物質である、サイクロスポリンA
(CysA)に対する、本人工毛球部の反応性を、単層
培養物との比較において検討した。
(2) Evaluation Using Test Agent (FIG. 2) Further, in order to examine the sensitivity of the artificial hair bulb, cyclosporin A, which is a known hair-promoting substance, is used.
The reactivity of the artificial hair bulb part to (CysA) was examined in comparison with the monolayer culture.

【0071】試験方法:上記の(4)に示した本評価
方法の実施態様に準じて、被験薬剤であるCysAを0 、1.
5 、5 、15μM 含有した培地を調製し、上記の(1)の
試験と同様に、培養法による呼吸量の違いを検討した。
Test method : In accordance with the embodiment of the present evaluation method shown in (4) above, the test drug CysA was 0, 1.
A medium containing 5, 5, and 15 µM was prepared, and the difference in respiration rate by the culture method was examined in the same manner as in the above-mentioned test (1).

【0072】第2図のグラフにおいて、横軸に、同一ウ
エルに播種した細胞の種類とCysAの濃度を、縦軸に相対
呼吸量を示した。また、各棒グラフの左側は単層培養法
の、右側は集塊培養法の結果を示している。
In the graph of FIG. 2, the horizontal axis shows the type of cells seeded in the same well and the concentration of CysA, and the vertical axis shows the relative respiratory volume. The left side of each bar graph shows the result of the monolayer culture method, and the right side shows the result of the agglutination culture method.

【0073】結果:単層培養したDPc、ORSc、
およびDPcとORScの共存培養での呼吸量は、CysA
の濃度に依存して低下していく傾向が認められたが、集
塊培養した場合、DPcの単一培養の時を除き、CysAに
よって呼吸量が増加する現象が認められた。その傾向
は、DPcとORScが共存した場合により強く現れ、
通常の細胞培養法では検出が難しい、CysAの発毛促進効
果を検出できていると考えられた。この結果により、本
人工毛球部は、単層培養物と比較して、極めて鋭敏に、
発毛促進物質に対して反応することが明らかとなった。
Results : monolayer cultured DPc, ORSc,
And the respiration rate of DPc and ORSc cocultured was CysA
However, when agglutination culture was performed, a phenomenon in which respiration was increased by CysA was observed except in the case of single culture of DPc. This tendency becomes stronger when DPc and ORSc coexist,
It is considered that CysA can detect the hair growth promoting effect, which is difficult to detect by the usual cell culture method. From this result, the present artificial hair bulb part is extremely sensitive as compared with the monolayer culture,
It became clear that it reacts to a hair growth promoting substance.

【0074】(3)細胞外マトリックス構成成分を用い
た効果の検討(第3図) さらに、細胞外マトリックス構成成分の被験培地におけ
る添加が、本人工毛球部の鋭敏性を向上させるかどうか
について検討するために、コラーゲンTypeIとデルマタ
ン硫酸を用いて、サイクロスポリンA(CysA)に対
する、本人工毛球部の反応性の比較を行った。
(3) Examination of effects using extracellular matrix constituents (Fig. 3) Furthermore, whether addition of extracellular matrix constituents to the test medium improves the sensitivity of the artificial hair bulb part. For examination, the reactivity of this artificial hair bulb part to cyclosporin A (CysA) was compared using collagen Type I and dermatan sulfate.

【0075】試験方法:上記の1ステップ法による本
人工毛球部の製造例において、初代毛乳頭細胞及び/又
は初代外毛根鞘細胞を細胞選別を行うためにインキュベ
ートする培地を、10μg/ml コラーゲンTypeI、1 μg/
mlデルマタン硫酸を含有させた、細胞外マトリックス構
成成分の添加培地として(対照は、コラーゲンTypeIと
1 μg/mlデルマタン硫酸を含有しないKeratinocyteSFM
培地)、1ステップ法により、細胞外マトリックス構成
成分処理を行った本人工毛球部(以下、マトリックス処
理本人工毛球部ともいう)を製造した。このマトリック
ス処理本人工毛球部に対して、上記(2)に記載した、
サイクロスポリンA(CysA)に対する試験を行っ
た。なお、被験培地は、CysAを、0又は5μM 含有させ
て、試験を行った。
Test method : In the production example of the present artificial hair bulb part by the above-mentioned one-step method, the medium in which primary papilla cells and / or primary outer root sheath cells are incubated for cell selection is 10 μg / ml collagen. Type I, 1 μg /
As a medium supplemented with extracellular matrix components containing ml dermatan sulfate (controls were collagen Type I and
Keratinocyte SFM without 1 μg / ml dermatan sulfate
Medium) A 1-step method was used to produce the present artificial hair bulb portion treated with extracellular matrix constituents (hereinafter, also referred to as matrix-treated present artificial hair bulb portion). For this matrix-treated artificial hair bulb part, as described in (2) above,
Tests against cyclosporin A (CysA) were performed. The test medium contained 0 or 5 μM of CysA for the test.

【0076】第3図は、横軸に、10μg/mlコラーゲンTy
peIと1 μg/mlデルマタン硫酸(ECM)の添加の有無
を示し、縦軸に相対呼吸量を示した。また、各棒グラフ
の左側は陰性コントロールであるCysA無添加(EtOH 0.1
% )の、右側は陽性コントロールである、5μM CysA添
加時の結果を示している。
In FIG. 3, the horizontal axis represents 10 μg / ml collagen Ty.
The presence or absence of the addition of peI and 1 μg / ml dermatan sulfate (ECM) was shown, and the vertical axis shows the relative respiratory volume. In addition, the left side of each bar graph is a negative control without addition of CysA (EtOH 0.1
The right side of () indicates the result when 5 μM CysA was added, which is a positive control.

【0077】結果:細胞外マトリックス成分の有無に
より、陰性コントロールに対する陽性コントロールの相
対呼吸量(%)は、それぞれ134.72±14.53 、119.87±
12.67 でであり、細胞外マトリックス成分の添加によっ
て、相対呼吸量が増加した。また、陰性コントロールに
対する両側t検定のp値はそれぞれ、p=0.0005 、p=
0.0109 であり、有意差の程度も増加した。陽性コント
ロール同士の比較でも、両側t検定のp値はp=0.034で
あり、細胞外マトリックス成分による、上皮系細胞及び
毛包間葉系細胞の接触処理により、本人工毛球部の被験
薬剤に対する感度を有意に向上させることができること
が明らかとなった。
Results : The relative respiration rates (%) of the positive control and the negative control were 134.72 ± 14.53 and 119.87 ±, respectively, depending on the presence or absence of the extracellular matrix component.
At 12.67, the addition of extracellular matrix components increased relative respiratory volume. Also, the p-values of the two-tailed t-test for the negative control are p = 0.0005 and p =
It was 0.0109, and the degree of significant difference also increased. Even in the comparison between the positive controls, the p-value of the two-sided t-test was p = 0.034, and by the contact treatment of the epithelial cells and the hair follicle-mesenchymal cells with the extracellular matrix component, the test drug in the artificial hair bulb part was tested. It was revealed that the sensitivity can be significantly improved.

【0078】(4)本評価方法の一般的な有用性につい
ての検討−1(第4図) さらに、本評価方法の一般性な有用性について検討する
ために、公知の多毛副作用薬剤であるVerapamil 、Diaz
oxide 、Pinacidil 、Latanoprost 、Minoxidil に対す
る、本人工毛球部の反応性を、呼吸量の変化を指標に検
討した。
(4) Examination on the general usefulness of this evaluation method-1 (Fig. 4) Furthermore, in order to examine the general usefulness of this evaluation method, Verapamil which is a known drug for hypertensive side effects. , Diaz
The reactivity of this artificial hair bulb part to oxide, Pinacidil, Latinoprost, and Minoxidil was examined using the change of respiratory volume as an index.

【0079】試験方法:上記の(2)に示したサイク
ロスポリンAを用いた試験において、サイクロスポリン
Aに代えて、被験薬剤として、Verapamil (0.001 、0.
01、0.1 、1 、10μM )、Diazoxide (0.001 、0.01、
0.1 、1 、10μM )、Pinacidil (0.01、0.1 、1 、1
0、100 μM )、Latanoprost (0.00001 、0.0001、0.0
01 、0.01、0.1nM )、Minoxidil (0.3 、1 、3 、1
0、30μM )を用いて、本評価方法における、本人工毛
球部の反応性を検討した。なお、陰性コントロールとし
て、0.1%エタノールを、陽性コントロールとして、
5μM CysAエタノール溶液を含有する上記のWillia
m's E(+)培地を用いた。
Test method : In the test using cyclosporin A shown in (2) above, instead of cyclosporin A, Verapamil (0.001, 0.
01, 0.1, 1, 10 μM), Diazoxide (0.001, 0.01,
0.1, 1, 10 μM), Pinacidil (0.01, 0.1, 1, 1
0, 100 μM), Latanoprost (0.00001, 0.0001, 0.0
01, 0.01, 0.1nM), Minoxidil (0.3, 1, 3, 1)
0, 30 μM) was used to examine the reactivity of the present artificial hair bulb part in the present evaluation method. As a negative control, 0.1% ethanol was used as a positive control.
The above William containing 5 μM CysA ethanol solution.
m's E (+) medium was used.

【0080】第4図のグラフの横軸に、被験薬剤の種類
と濃度を、縦軸に相対呼吸量(%)を示した。結果 :Diazoxide およびPinacidil を除き、両側t検
定で、CysA、Verapamil 、Latanoprost 、Minoxidil に
有意な呼吸量の増加が認められ、作用機序の異なる多毛
副作用薬剤が、呼吸量の変化といった簡易な指標を適用
した本評価方法で選択可能なことが見いだされ、本評価
法の有用性が証明された。
The abscissa of the graph in FIG. 4 shows the type and concentration of the test drug, and the ordinate shows the relative respiratory volume (%). Results : CysA, Verapamil, Latanoprost, and Minoxidil showed a significant increase in respiratory volume in a two-tailed t-test, except for Diazoxide and Pinacidil. It was found that the applied evaluation method was selectable, and the usefulness of this evaluation method was proved.

【0081】(5)本評価方法の一般的な有用性につい
ての検討−2(第5図) 育毛主剤として知られているオタネニンジンエキス(丸
善製薬社製)を、被験薬剤として、本評価方法と被験薬
剤自体の有用性について検討した。
(5) Examination on the general usefulness of the present evaluation method-2 (Fig. 5) Using this ginseng extract (manufactured by Maruzen Pharmaceutical Co., Ltd.), which is known as a main hair-growing agent, as a test agent, The usefulness of the test drug itself was examined.

【0082】1ステップ法または2ステップ法により得
た本人工毛球部が形成されている、96穴プレートの各
ウエルに、オタネニンジンエキスを含有する、William'
s E(+)培地を、80μl ずつ、各ウエルに添加し、37
℃、5%CO2 下で、2日間さらに培養を行った。
William's containing ginseng extract in each well of a 96-well plate in which the present artificial hair bulb obtained by the one-step method or the two-step method is formed.
80 μl of s E (+) medium was added to each well.
Further culturing was carried out at 5 ° C. under 5% CO 2 for 2 days.

【0083】なお、陰性コントロールとして、0.1%
エタノールを、陽性コントロールとして、5μM Cys
Aエタノール溶液を含有する上記のWilliam's E(+)培地
を用いた。
As a negative control, 0.1%
Ethanol as a positive control, 5 μM Cys
The above William's E (+) medium containing A ethanol solution was used.

【0084】アラマーブルー(Biosource:DAL1000) 、S
FM培地、William's E(+)培地を、それぞれ、2:1:
1(容量比)の割合で混合し、37℃に温めた後、40
μlずつ、各ウエルに添加し、37℃で6時間の反応を
行った。反応終了後、各ウエルから、100μl ずつの
反応液を採取し、蛍光測定用白色96穴プレート(Opaqu
e Plate)(Coster:3912) の各ウエルに分注した。
Alamar Blue (Biosource: DAL1000), S
FM medium and William's E (+) medium were added in a ratio of 2: 1:
After mixing at a ratio of 1 (volume ratio) and warming to 37 ° C, 40
μl was added to each well and the reaction was carried out at 37 ° C. for 6 hours. After the reaction was completed, 100 μl of the reaction solution was collected from each well and the white 96-well plate for fluorescence measurement (Opaqu
e Plate) (Coster: 3912).

【0085】各ウエルの蛍光強度を、励起波長544n
m、蛍光波長590nmに設定した、Labsystems Fluorosk
an II(大日本製薬社)で測定し、細胞を培養していな
い反応液(培地そのもの)の蛍光強度を差し引いて、各
条件下での相対呼吸量(%)を求めた。
The fluorescence intensity of each well was measured at the excitation wavelength of 544n.
Labsystems Fluorosk with m and fluorescence wavelength of 590 nm
It was measured with an II (Dainippon Pharmaceutical Co., Ltd.) and the fluorescence intensity of the reaction solution (medium itself) in which the cells were not cultured was subtracted to determine the relative respiration rate (%) under each condition.

【0086】被験薬剤であるオタネニンジンエキスの最
終濃度を、0.1、1.0、10.0ppm として評価を
行った結果、0.1および1.0ppm で、相対呼吸量
が、それぞれ、118±14%、110±11%に増加
した。両側t検定を行った結果、0.1%で傾向差(0.0
5<p<0.1)が認められた(第5図)。
The final concentration of Panax ginseng extract, which is a test drug, was evaluated as 0.1, 1.0, 10.0 ppm, and the results were 0.1 and 1.0 ppm, respectively, and the relative respiratory volumes were 118 ±, respectively. 14% and 110 ± 11%. As a result of performing a two-tailed t-test, the tendency difference (0.0
5 <p <0.1) was observed (Fig. 5).

【0087】この結果により、本人工毛球部を用いた本
評価方法により、オタネニンジンエキスの育毛効果を検
出できたことがわかる。これにより、オタネニンジンエ
キスに代えて、育毛効果が未知の物質を被験薬剤として
用いた場合も、被験薬剤が育毛効果を有する場合には、
この被験薬剤が本評価方法により検出され得ることが明
らかとなった。
From these results, it can be seen that the hair-growing effect of Panax ginseng extract could be detected by the present evaluation method using the present artificial hair bulb part. Thus, instead of the Panax ginseng extract, even when using a substance with unknown hair-growth effect as a test drug, when the test drug has a hair-growing effect,
It was revealed that this test drug can be detected by this evaluation method.

【0088】なお、上記の本人工毛乳頭の製造工程にお
ける本人工毛乳頭の顕微鏡写真(4倍)を第6図(2ス
テップ法)および第7図(1ステップ法)に示す。第6
図においては、はじめは分散していた毛包間葉系細胞が
1日で細胞集塊を形成し、これに外毛根鞘細胞を添加す
ると、添加後1日程度で、外毛根鞘細胞が毛包間葉系細
胞の細胞集塊の周りに細胞接着した状態で細胞選別され
ることが示されており、2ステップ法の有用性が明らか
となっている。
A microscopic photograph (4 times) of the artificial nipple of the present invention in the above-mentioned manufacturing process of the artificial nipple is shown in FIG. 6 (two-step method) and FIG. 7 (one-step method). Sixth
In the figure, the hair follicle mesenchymal cells that were initially dispersed form cell clumps in 1 day, and if outer hair root sheath cells are added to this, the outer hair root sheath cells become It has been shown that cells are sorted in the state of cell adhesion around the cell clumps of basilar mesenchymal cells, demonstrating the usefulness of the two-step method.

【0089】第7図においては、はじめは分散していた
毛包間葉系細胞と外毛根鞘細胞が、時間経過と共に、毛
包間葉系細胞が中心部で細胞集塊を形成しつつ、外毛根
鞘細胞は、細胞選別によってその周りに細胞接着してお
り、この再構成過程は、2日間程度で完了することが示
されている。
In FIG. 7, the hair follicle mesenchymal cells and the outer root sheath cells which were initially dispersed, formed a cell clump in the central portion of the hair follicle mesenchymal cells with the passage of time, The outer root sheath cells are cell-adhered around them by cell sorting, and this reconstitution process has been shown to be completed in about 2 days.

【0090】[0090]

【発明の効果】本発明により、可能な限り、実際の毛包
や毛球部の状態を反映し得る、育毛剤の新たな評価手段
を提供し得る細胞培養素材と、この培養素材を用いた育
毛剤の評価手段が提供される。
EFFECTS OF THE INVENTION According to the present invention, a cell culture material capable of providing a new means for evaluating a hair-growing agent, which can reflect the actual state of hair follicles and hair bulbs, and this culture material were used. A means for evaluating a hair restorer is provided.

【図面の簡単な説明】[Brief description of drawings]

【図1】単層培養法と細胞集塊培養法(本評価方法)に
よる呼吸量の違いについて示した図面である。
FIG. 1 is a drawing showing a difference in respiratory volume between a monolayer culture method and a cell agglutination culture method (this evaluation method).

【図2】単層培養法と細胞集塊培養法(本評価方法)に
よるCysAに対する反応性の違いを相対呼吸量(%)で示
した図面である。
FIG. 2 is a drawing showing the difference in reactivity to CysA by the monolayer culture method and the cell agglutination culture method (the present evaluation method) in terms of relative respiratory rate (%).

【図3】本評価方法における細胞外マトリックス成分の
添加の有用性について検討した結果を示した図面であ
る。
FIG. 3 is a drawing showing the results of examining the usefulness of the addition of extracellular matrix components in the present evaluation method.

【図4】ヒトで多毛副作用が知られている薬剤を被験薬
剤として、本評価方法の有用性について検討した結果を
示した図面である。
FIG. 4 is a drawing showing the results of examining the usefulness of the present evaluation method using a drug known to have a hairy side effect in humans as a test drug.

【図5】育毛主剤として知られているオタネニンジンエ
キスを被験薬剤として、本評価方法の有用性について検
討した結果を示した図面である。
FIG. 5 is a drawing showing the results of examining the usefulness of the present evaluation method using Panax ginseng extract, which is known as the main agent for hair growth, as a test drug.

【図6】2ステップ法による本人工毛球部の製造工程に
おける細胞集塊の外観を示した図面である。
FIG. 6 is a view showing the appearance of cell clumps in the manufacturing process of the present artificial hair bulb part by the two-step method.

【図7】1ステップ法による本人工毛球部の製造工程に
おける細胞集塊の外観を示した図面である。
FIG. 7 is a view showing the appearance of cell clumps in the manufacturing process of the present artificial hair bulb part by the one-step method.

Claims (15)

【特許請求の範囲】[Claims] 【請求項1】毛包間葉系細胞の細胞集塊の外側に、上皮
系細胞が細胞接着している、人工毛球部。
1. An artificial hair bulb part in which epithelial cells are cell-adhered to the outside of a cell aggregate of hair follicle mesenchymal cells.
【請求項2】毛包間葉系細胞の細胞集塊が、上皮系細胞
により包埋された状態で、毛包間葉系細胞の細胞集塊の
外側に、上皮系細胞が細胞接着している、請求項1記載
の人工毛球部。
2. An epithelial cell adheres to the outside of the hair follicle mesenchymal cell aggregate when the hair follicle mesenchymal cell aggregate is embedded in the epithelial cells. The artificial hair bulb according to claim 1, wherein
【請求項3】上皮系細胞及び毛包間葉系細胞が、細胞外
マトリクス構成成分で接触処理された上皮系細胞及び毛
包間葉系細胞である、請求項1又は2記載の人工毛球
部。
3. The artificial hair bulb according to claim 1, wherein the epithelial cells and hair follicle mesenchymal cells are epithelial cells and hair follicle mesenchymal cells that have been contact-treated with an extracellular matrix constituent. Department.
【請求項4】毛包間葉系細胞が毛乳頭細胞である、請求
項1〜3のいずれかの請求項記載の人工毛球部。
4. The artificial hair bulb part according to claim 1, wherein the hair follicle mesenchymal cells are hair papilla cells.
【請求項5】培養液中において、毛包間葉系細胞の細胞
集塊を形成させ、次いで、この細胞集塊と上皮系細胞
を、培養液中で共存させて、細胞選別現象により、毛包
間葉系細胞の細胞集塊の周囲に上皮系細胞を細胞接着さ
せることにより、毛包間葉系細胞の細胞集塊の外側に上
皮系細胞が細胞接着している人工毛球部を製造する、人
工毛球部の製造方法。
5. In a culture medium, a cell clump of hair follicle mesenchymal cells is formed, and then this cell clump and an epithelial cell are allowed to coexist in the culture medium, and the hair is separated by a cell sorting phenomenon. Manufactures artificial hair bulbs in which epithelial cells are cell-adhered to the outside of hair follicle mesenchymal cell aggregates by adhering epithelial cells around the cell aggregates of follicular mesenchymal cells A method of manufacturing an artificial hair bulb part.
【請求項6】培養液中において、毛包間葉系細胞と上皮
系細胞とを共存させて、細胞選別現象により、毛包間葉
系細胞の細胞集塊を形成させると共に、この細胞集塊の
周囲に上皮系細胞を細胞接着させることにより、毛包間
葉系細胞の細胞集塊の外側に上皮系細胞が細胞接着して
いる人工毛球部を製造する、人工毛球部の製造方法。
6. In a culture medium, hair follicle mesenchymal cells and epithelial cells are allowed to coexist to form a cell agglomerate of hair follicle mesenchymal cells by a cell sorting phenomenon, and the cell agglomerates are formed. A method for producing an artificial hair bulb part, in which an epithelial cell part is adhered to the outside of a cell clump of hair follicle mesenchymal cells by cell-adhering epithelial cells around the ..
【請求項7】培養液中に細胞外マトリクス構成成分が含
まれている、請求項5又は6記載の人工毛球部の製造方
法。
7. The method for producing an artificial hair bulb according to claim 5, wherein the culture medium contains extracellular matrix constituent components.
【請求項8】請求項1〜4のいずれかの請求項記載の人
工毛球部に対して被験薬剤を作用させた場合の人工毛球
部における現象を、被験薬剤の毛髪に対する作用と関連
付けて、毛髪に対する作用を有する被験薬剤を評価す
る、被験薬剤の評価方法。
8. A phenomenon in an artificial hair bulb part when a test drug acts on the artificial hair bulb part according to any one of claims 1 to 4, in association with the action of the test drug on hair. A method for evaluating a test drug, wherein a test drug having an effect on hair is evaluated.
【請求項9】請求項1〜4のいずれかの請求項記載の人
工毛球部、および、他の細胞種若しくは組織との共存下
で、被験薬剤を作用させた場合の人工毛球部における現
象を、被験薬剤の毛髪に対する作用と関連付けて、毛髪
に対する作用を有する被験薬剤を評価する、被験薬剤の
評価方法。
9. An artificial hair bulb portion according to any one of claims 1 to 4 and an artificial hair bulb portion when a test drug is allowed to act in the coexistence with other cell types or tissues. A method for evaluating a test drug, which relates a phenomenon to the effect of a test drug on hair to evaluate a test drug having an effect on hair.
【請求項10】被験薬剤の毛髪に対する作用が、育毛作
用である、請求項8又は9記載の被験薬剤の評価方法。
10. The method for evaluating a test drug according to claim 8, wherein the action of the test drug on hair is a hair-growth action.
【請求項11】請求項1〜4のいずれかの請求項記載の
人工毛球部における内因性の物質に関する現象を、その
内因性の物質が関わるべき毛髪における現象と関連付け
て、毛髪に関連する内因性の物質を見出す、毛髪関連物
質の検索方法。
11. A hair-related phenomenon in which the endogenous substance-related phenomenon in the artificial hair bulb according to any one of claims 1 to 4 is associated with a phenomenon in hair to which the endogenous substance should be related. A method for searching hair-related substances for finding endogenous substances.
【請求項12】請求項1〜4のいずれかの請求項記載の
人工毛球部、および、他の細胞種若しくは組織との共存
下において、人工毛球部における内因性の物質に関する
現象を、その内因性の物質が関わるべき毛髪における現
象と関連付けて、毛髪に関連する内因性の物質を見出
す、毛髪関連物質の検索方法。
12. An artificial hair bulb portion according to any one of claims 1 to 4, and a phenomenon relating to an endogenous substance in the artificial hair bulb portion in the coexistence with other cell types or tissues, A method for searching a hair-related substance, which finds an endogenous substance related to hair in association with a phenomenon in hair to which the endogenous substance should be related.
【請求項13】毛髪関連物質が、養毛作用を有する物質
である、請求項11または12の毛髪関連物質の検索方
法。
13. The method for retrieving a hair-related substance according to claim 11 or 12, wherein the hair-related substance is a substance having a hair nourishing action.
【請求項14】請求項1〜4のいずれかの請求項記載の
人工毛球部を構成要素として含み、被験薬剤を作用させ
た場合の人工毛球部における現象を、被験薬剤の毛髪に
対する作用と関連付けて、毛髪に対する作用を有する被
験薬剤を評価する方法を行うためのキット。
14. An action of a test drug on hair, which comprises the artificial hair bulb of any one of claims 1 to 4 as a constituent element and which causes a phenomenon in the artificial hair bulb when the test drug is allowed to act. A kit for carrying out a method for evaluating a test agent having an effect on hair in association with.
【請求項15】被験薬剤の毛髪に対する作用が、養毛作
用である、請求項14記載のキット。
15. The kit according to claim 14, wherein the action of the test drug on hair is a hair-feeding action.
JP2001269277A 2001-09-05 2001-09-05 Artificial hair bulb part, method for producing the same, and drug evaluation method using artificial hair bulb part Expired - Lifetime JP4822635B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001269277A JP4822635B2 (en) 2001-09-05 2001-09-05 Artificial hair bulb part, method for producing the same, and drug evaluation method using artificial hair bulb part

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001269277A JP4822635B2 (en) 2001-09-05 2001-09-05 Artificial hair bulb part, method for producing the same, and drug evaluation method using artificial hair bulb part

Publications (2)

Publication Number Publication Date
JP2003070466A true JP2003070466A (en) 2003-03-11
JP4822635B2 JP4822635B2 (en) 2011-11-24

Family

ID=19095126

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001269277A Expired - Lifetime JP4822635B2 (en) 2001-09-05 2001-09-05 Artificial hair bulb part, method for producing the same, and drug evaluation method using artificial hair bulb part

Country Status (1)

Country Link
JP (1) JP4822635B2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005132813A (en) * 2003-10-06 2005-05-26 Shiseido Co Ltd Method and composition for regenerating hair folicle, and animal supporting regenerated follicle
WO2005053763A1 (en) * 2003-12-05 2005-06-16 Biointegrence Inc. Hair growth method
JP2007274949A (en) * 2006-04-05 2007-10-25 Shiseido Co Ltd Method for culturing hair papilla cell
JP2008306938A (en) * 2007-06-12 2008-12-25 Shiseido Co Ltd Method for culturing hair papilla cell
JP2010161953A (en) * 2009-01-13 2010-07-29 Dainippon Printing Co Ltd Method for producing biological tissue
JP2010161954A (en) * 2009-01-13 2010-07-29 Dainippon Printing Co Ltd Method for producing biological tissue
JP2010161952A (en) * 2009-01-13 2010-07-29 Dainippon Printing Co Ltd Method for producing biological tissue
US7985537B2 (en) 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
JP2014023540A (en) * 2013-11-06 2014-02-06 Dainippon Printing Co Ltd Producing method of living tissue
US9023380B2 (en) 2005-11-22 2015-05-05 Aderans Research Institute, Inc. Hair follicle graft from tissue engineered skin
WO2017217393A1 (en) * 2016-06-17 2017-12-21 国立大学法人横浜国立大学 Cell-embedded beads for hair regeneration and method for producing same, and kit for hair regeneration
WO2019220843A1 (en) 2018-05-16 2019-11-21 国立大学法人横浜国立大学 Cell-containing hydrogel body and method for producing same
WO2019235375A1 (en) * 2018-06-04 2019-12-12 株式会社オーガンテクノロジーズ Method for producing regenerative hair follicle germs
US10865373B2 (en) 2015-10-30 2020-12-15 National University Corporation Yokohama National University Regenerated hair follicle primordium aggregation manufacturing method, hair follicle tissue-containing sheet, and method for manufacturing hair follicle tissue-containing sheet
WO2022265021A1 (en) * 2021-06-15 2022-12-22 株式会社 資生堂 Composition containing atelocollagen and dermal sheath cup (dsc) cells, kit for regrowing hair, method for manufacturing composition for regrowing hair, and method for regrowing hair
WO2023210402A1 (en) * 2022-04-28 2023-11-02 株式会社 資生堂 Method for evaluating hair regeneration ability of dermal sheath cup (dsc) cells, composition for hair regeneration and manufacturing method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10136977A (en) * 1996-11-11 1998-05-26 Toyobo Co Ltd Artificial tissue containing tissue-attached organ-like structure and its production
WO2000029553A1 (en) * 1998-11-19 2000-05-25 Organogenesis Inc. Bioengineered tissue constructs and methods for producing and using them
JP2000297015A (en) * 1999-02-10 2000-10-24 Taisho Pharmaceut Co Ltd Hair tonic and method for screening substance having hair-restoring action

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10136977A (en) * 1996-11-11 1998-05-26 Toyobo Co Ltd Artificial tissue containing tissue-attached organ-like structure and its production
WO2000029553A1 (en) * 1998-11-19 2000-05-25 Organogenesis Inc. Bioengineered tissue constructs and methods for producing and using them
JP2000297015A (en) * 1999-02-10 2000-10-24 Taisho Pharmaceut Co Ltd Hair tonic and method for screening substance having hair-restoring action

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4689175B2 (en) * 2003-10-06 2011-05-25 株式会社資生堂 Composition, method for regenerating hair follicle and animal carrying regenerated hair follicle
JP2005132813A (en) * 2003-10-06 2005-05-26 Shiseido Co Ltd Method and composition for regenerating hair folicle, and animal supporting regenerated follicle
WO2005053763A1 (en) * 2003-12-05 2005-06-16 Biointegrence Inc. Hair growth method
US9023380B2 (en) 2005-11-22 2015-05-05 Aderans Research Institute, Inc. Hair follicle graft from tissue engineered skin
JP2007274949A (en) * 2006-04-05 2007-10-25 Shiseido Co Ltd Method for culturing hair papilla cell
JP2008306938A (en) * 2007-06-12 2008-12-25 Shiseido Co Ltd Method for culturing hair papilla cell
US7985537B2 (en) 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
US9440004B2 (en) 2009-01-13 2016-09-13 Dai Nippon Printing Co., Ltd. Method for preparing biological tissue
JP2010161954A (en) * 2009-01-13 2010-07-29 Dainippon Printing Co Ltd Method for producing biological tissue
US9206391B2 (en) 2009-01-13 2015-12-08 Dai Nippon Printing Co., Ltd. Method for preparing biological tissue
JP2010161953A (en) * 2009-01-13 2010-07-29 Dainippon Printing Co Ltd Method for producing biological tissue
JP2010161952A (en) * 2009-01-13 2010-07-29 Dainippon Printing Co Ltd Method for producing biological tissue
JP2014023540A (en) * 2013-11-06 2014-02-06 Dainippon Printing Co Ltd Producing method of living tissue
US10865373B2 (en) 2015-10-30 2020-12-15 National University Corporation Yokohama National University Regenerated hair follicle primordium aggregation manufacturing method, hair follicle tissue-containing sheet, and method for manufacturing hair follicle tissue-containing sheet
WO2017217393A1 (en) * 2016-06-17 2017-12-21 国立大学法人横浜国立大学 Cell-embedded beads for hair regeneration and method for producing same, and kit for hair regeneration
CN109415695A (en) * 2016-06-17 2019-03-01 国立大学法人横浜国立大学 Hair regeneration is with cell embedding pearl and preparation method thereof and hair regeneration kit
JPWO2017217393A1 (en) * 2016-06-17 2019-05-09 国立大学法人横浜国立大学 Cell-embedded beads for hair regeneration, method for producing the same, and kit for hair regeneration
JP7044330B2 (en) 2016-06-17 2022-03-30 国立大学法人横浜国立大学 Cell-embedded beads for hair regeneration and their manufacturing method, and hair regeneration kit
WO2019220843A1 (en) 2018-05-16 2019-11-21 国立大学法人横浜国立大学 Cell-containing hydrogel body and method for producing same
JP2019198267A (en) * 2018-05-16 2019-11-21 国立大学法人横浜国立大学 Cell-containing hydrogel body and method for manufacturing the same
JP7142840B2 (en) 2018-05-16 2022-09-28 国立大学法人横浜国立大学 Cell-containing hydrogel and method for producing the same
WO2019235375A1 (en) * 2018-06-04 2019-12-12 株式会社オーガンテクノロジーズ Method for producing regenerative hair follicle germs
CN112543805A (en) * 2018-06-04 2021-03-23 株式会社器官再生工学 Method for producing regenerated hair blastocyst
JPWO2019235375A1 (en) * 2018-06-04 2021-06-17 株式会社オーガンテクノロジーズ Manufacturing method of regenerated hair follicle primordium
WO2022265021A1 (en) * 2021-06-15 2022-12-22 株式会社 資生堂 Composition containing atelocollagen and dermal sheath cup (dsc) cells, kit for regrowing hair, method for manufacturing composition for regrowing hair, and method for regrowing hair
WO2023210402A1 (en) * 2022-04-28 2023-11-02 株式会社 資生堂 Method for evaluating hair regeneration ability of dermal sheath cup (dsc) cells, composition for hair regeneration and manufacturing method thereof

Also Published As

Publication number Publication date
JP4822635B2 (en) 2011-11-24

Similar Documents

Publication Publication Date Title
JP2003070466A (en) Artificial hair-bulb and method for producing the same, and method for assessing cosmetological agent by using the same
Michel et al. Characterization of a new tissue-engineered human skin equivalent with hair
Bernard Hair shape of curly hair
Roh et al. Dermal papilla-induced hair differentiation of adult epithelial stem cells from human skin
JP5442588B2 (en) Hair follicle mesenchymal stem cells and uses thereof
AU2009228756B2 (en) Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations
EP2455111B1 (en) Cell mass capable of serving as a primitive organ-like structure comprised of a plurality of cell types of somatic origin
Matulionis Morphology of the developing down feathers of chick embryos: a descriptive study at the ultrastructural level of differentiation and keratinization
Wiszniewski et al. Differential expression of connexins during stratification of human keratinocytes
Barthel et al. Epidermal stem cells
Lin et al. Expression of Wnt/β-catenin signaling, stem-cell markers and proliferating cell markers in rat whisker hair follicles
Watt Epidermal stem cells as targets for gene transfer
JP2005525088A (en) Skin / hair equivalent with reconstituted teat
KR102251129B1 (en) Methods and compositions to modulate hair growth
JP2004505614A (en) 3D skin model
Miller et al. Keratinocyte stem cells of cornea, skin and hair follicle: common and distinguishing features
Deshayes et al. Human long-term deregulated circadian rhythm alters regenerative properties of skin and hair precursor cells
Schor et al. The synthesis of subendothelial matrix by bovine aortic endothelial cells in culture
JP2017113030A (en) Reconstructed scalp model and process for screening active molecules
Umino et al. Modification of type I collagenous gels by alveolar epithelial cells
WO2003022043A1 (en) Hair follicle-reconstitution system and animal carrying the same
WO2022222848A1 (en) Skin microspheres, preparation method therefor, and application thereof
JP2020080680A (en) Composition for reconstructing human skin tissue having hair follicles, human skin tissue model animal, and production method thereof
Jindo et al. Organ culture of mouse vibrissal hair follicles in serum‐free medium
JPH10229978A (en) Method of detecting hair growth

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100907

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101108

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110906

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110906

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4822635

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140916

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term